Trials / Unknown
UnknownNCT03601260
The Percentage of Cases of Acute Treatment With Allopurinol in Gout Patients
To Examine the Percentage of Cases of Acute Treatment With Allopurinol in Gout Patients as Secondary Treatment
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 700 (estimated)
- Sponsor
- Hillel Yaffe Medical Center · Other Government
- Sex
- All
- Age
- 25 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to determine the percentage of cases of acute treatment with Allopurinol in gout patients who have been previously treated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Allopurinol | Treatment of gout patients by oral dosage of 100 mg-300mg/ day of Allopurinol |
Timeline
- Start date
- 2018-08-01
- Primary completion
- 2018-12-01
- Completion
- 2018-12-01
- First posted
- 2018-07-26
- Last updated
- 2018-07-26
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT03601260. Inclusion in this directory is not an endorsement.